Zhang Liwen, Su Xiaodan, Liu Shujun, Knapp Amy R, Parthun Mark R, Marcucci Guido, Freitas Michael A
Mass Spectrometry and Proteomics Facility, Campus Chemical Instrument Center, Department of Chemistry, Division of Hematology/Oncology, The Ohio State University, Columbus, Ohio 43210, USA.
J Proteome Res. 2007 Jan;6(1):81-8. doi: 10.1021/pr060139u.
Disrupted patterns of acetylation and deacetylation of core histones play an important role in silencing transcription of hematopoietic important genes in acute myeloid leukemia (AML). A thorough investigation of these mechanisms and the response to pharmacologic modifiers will provide a better understanding of the role of histone acetylation in leukemogenesis. We describe here an analytical approach that combines acid urea polyacrylamide gel electrophoresis (AU-PAGE), amino acid coded mass tagging (AACM), and mass spectrometry (MS) for the investigation of histone acetylation patterns. The combined approach was used to follow the dynamics of H4 acetylation in Kasumi-1 cells harboring the fusion gene AML1/ETO shown to aberrantly recruit histone deacetylases (HDACs). The histones in Kasumi-1 cells were labeled by growing the cells in media in which lysine was replaced with stable isotope-labeled lysine (Lys-D4). Labeled and unlabeled cells were treated with depsipeptide and analyzed at different time points (0, 4, 8, 12, 24, and 48 h). The cells were mixed, the histone was extracted, and acetylated H4 isoforms were separated using AU-PAGE before in-gel trypsin digestion. The digests were analyzed by MALDI-TOF MS. Peptides were identified by mass and isotope pattern. LC-MS/MS of Arg-C digests were also performed to verify the acetylation pattern for H4. The major pattern of acetylation was determined as follows: initial acetylation at K16, followed by acetylation at K12, and finally acetylation of either K8 and/or K5.
核心组蛋白乙酰化和去乙酰化模式的破坏在急性髓系白血病(AML)中造血重要基因转录沉默方面发挥重要作用。对这些机制以及对药理修饰剂的反应进行深入研究将有助于更好地理解组蛋白乙酰化在白血病发生中的作用。我们在此描述一种结合酸性尿素聚丙烯酰胺凝胶电泳(AU-PAGE)、氨基酸编码质量标记(AACM)和质谱(MS)的分析方法,用于研究组蛋白乙酰化模式。该联合方法用于追踪携带融合基因AML1/ETO的Kasumi-1细胞中H4乙酰化的动态变化,该融合基因显示会异常募集组蛋白去乙酰化酶(HDACs)。通过在赖氨酸被稳定同位素标记的赖氨酸(Lys-D4)替代的培养基中培养细胞,对Kasumi-1细胞中的组蛋白进行标记。标记和未标记的细胞用缩肽处理,并在不同时间点(0、4、8、12、24和48小时)进行分析。将细胞混合,提取组蛋白,在胶内胰蛋白酶消化前使用AU-PAGE分离乙酰化的H4异构体。通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)分析消化产物。通过质量和同位素模式鉴定肽段。还进行了Arg-C消化产物的液相色谱-串联质谱(LC-MS/MS)分析以验证H4的乙酰化模式。乙酰化的主要模式确定如下:首先在K16处乙酰化,接着在K12处乙酰化,最后在K8和/或K5处乙酰化。